40 likes | 53 Views
<br>The global indapamide market is estimated to grow significantly at a CAGR of over 2.0% during the forecast period. A significant rise in the incidences of high blood pressure (hypertension) and congestive heart failure is primarily contributing to the growth of the market.<br>
E N D
Orion Market Research Indapamide Market Trends, Size, Forecast - 2020-2026 Request a free sample of our https://www.omrglobal.com/request-sample/indapamide-market ------------------------------------------------------------------------------------------------------ report on Indapamide Market: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404
The global indapamide market is estimated to grow significantly at a CAGR of over 2.0% during the forecast period. A significant rise in the incidences of high blood pressure (hypertension) and congestive heart failure is primarily contributing to the growth of the market. High blood pressure affects approximately a third of the adult population across the globe and is the most common cause of CVD-related mortalities. As per the data published by the American Health Association (AHA) in January 2018, 103 million US adults were suffering from high blood pressure, which is nearly half of all adults in the US. Request https://www.omrglobal.com/request-sample/indapamide-market The global indapamide market is segmented on the basis of product and application. a free sample of our report on Indapamide Market: Based on the product, the market is bifurcated into 1.25 mg indapamide and 2.5 mg indapamide. Among these, the market for 1.25 mg medicine held a significant market share owing to the extensive application of the drug in treating high blood pressure or hypertension. Based on the application, the market is segmented into high blood pressure, heart failure, and others. The high blood pressure segment is projected to have a significant share in the market. Growing incidence of hypertension is contributing to the segmental growth as indapamide drugs are significantly used to treat hypertension while reducing the risk of developing serious heart conditions. A full report of Indapamide Market Is available at https://www.omrglobal.com/industry-reports/indapamide-market Global Indapamide Market Segmentation By Product 1.25 MG
2.5 MG By Application High Blood Pressure Heart Failure Others Regional Analysis North America oUS oCanada Europe oUK oGermany oItaly oSpain oFrance oRest of Europe Asia-Pacific oChina oJapan oIndia oRest of Asia-Pacific Rest of the World
Company Profiles ANI Pharmaceuticals, Inc. Apotex Inc. BioindustriaL.I.M. S.p.A. Glenmark Pharmaceuticals Ltd. Grupo Azevedos Krka Group Laboratori Baldacci S.p.A. Merck KGaA Mylan N.V. Preferred Pharmaceuticals, Inc For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/indapamide-market About us: Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research- based services. For More Information, Visit https://www.omrglobal.com/ Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404